- Ngā maimoatanga
- Ngā Whakaaturanga
- Neuroblastoma
- Puku totoka
- Ngā Whakaaturanga
- TIL
- Te Whakaora Pūtau NK
- Te Maistenia Gravis (MG)
- Te Mate Pūkahukahu Lymphoblastic Whakapeka (B-ALL)
- Lupus Erythematosus Pūnaha (SLE)
- Te mate pukupuku lymphoblastic whakapeka (T-ALL)
- Lymphoma Kore-Hodgkin (NHL)
- Myeloma maha (MM)
- Lymphom Pūtau-B Nui e horapa ana
- Leukemia B-lymphocytic
- Myeloma
Te Whakaora CAR-T mō te Lymphoma Non-Hodgkin (NHL)
Tirohanga Whānui
Ko te Non-Hodgkin Lymphoma (NHL) he rōpū matepukupuku toto kanorau e ahu mai ana i te pūnaha lymphatic, me ngā momo rerekē, tae atu ki ngā lymphoma pūtau-B me ngā lymphoma pūtau-T. I roto i ēnei, Lymphoma Pūtau-B Nui Marara (DLBCL) Ko te momo NHL pūtau-B tino noa, tino kaha hoki. Ahakoa ngā whanaketanga o te chemotherapy me te immunotherapy, he maha ngā tūroro e hoki whakamuri ana te mate NHL, e uaua ana rānei ki te whiwhi i ngā whiringa maimoatanga iti. Te rongoā CAR-T e tuku ana i tētahi huarahi hou, e whakarato ana i te tumanako mō ngā tūroro kāore anō kia aro mai ō rātou lymphoma ki ngā maimoatanga tuku iho.
He aha te rongoā CAR-T mō te NHL?
Ko te rongoā CAR-T (Chimeric Antigen Receptor T-cell) he rongoā ārai mate hou e uru ana ki te whakarerekē i ngā pūtau-T o te tūroro kia whakaatu i tētahi kaiwhakawhiwhi e aro ana ki ngā pūtau matepukupuku. Mō te NHL, ko te rongoā CAR-T te aro nui ki CD19 me CD20 ngā antigens i runga i ngā pūtau-B, e kitea whānuitia ana i runga i ngā pūtau lymphoma kino. Mā te whakarei ake i te kaha o ngā pūtau-T ki te kite me te whakaeke i ēnei pūtau matepukupuku, ka tukuna e te rongoā CAR-T he kōwhiringa maimoatanga whai hua mō ngā tūroro he lymphoma kua hoki mai, he lymphoma uaua rānei.
Ngā Painga Matua o te Whakaora CAR-T mō te NHL
- He whai hua mō te NHL kua hoki whakamuri me te uaua ki te mahiKua whakaatuhia e te rongoā CAR-T he tino whai huatanga i roto i ngā tūroro e pāngia ana e te DLBCL me ētahi atu momo NHL pūtau-B kāore anō kia urupare ki ngā momo rongoā maha.
- Te Tika WhaiaroKa arotahi te rongoā ki ngā pūtau-B matepukupuku, engari kāore e pā kino ki ngā pūtau hauora, ka whakaiti i ngā pānga taha e pā pinepine ana ki ngā rongoā tuku iho.
- Maimoatanga WhaiaroKa whakamahia e te rongoā CAR-T ngā pūtau-T o te tūroro, e tuku ana i tētahi huarahi maimoatanga kua whakaritea mō te āhua motuhake o te tangata.
- Te Pūmanawa mō te Whakamarietanga Mo Te Wā RoaHe maha ngā tūroro kua ora katoa, kua ora katoa rānei i muri i te rongoā CAR-T, ko ētahi kei te ora tonu mō te wā roa, ahakoa he maha ngā wā o te rongoā chemotherapy.
Tukanga Maimoatanga
- Kohinga pūtau-TKa tangohia ngā pūtau-T mai i te toto o te tūroro mā te tukanga e kiia nei ko te leukapheresis, he rite ki te tuku toto.
- Te hanga i ngā pūtau-TI roto i te taiwhanga, ka whakarerekētia ngā pūtau-T kua kohia hei whakaatu i ngā kaiwhakawhiwhi e aro ana ki ngā antigens motuhake pēnei i CD19 rānei CD20 kitea i runga i ngā pūtau lymphoma.
- Te Whaowhia CAR-TKia whānuitia, kia whakarerekētia hoki ngā pūtau-T, ka whakahokia ki roto i te toto o te tūroro hei whakaeke i ngā pūtau lymphoma.
- Aroturuki me te WhakaoraWhai muri i te werohanga, ka tirotirohia ngā tūroro mō ngā pānga taha, pērā i te cytokine release syndrome (CRS) me te neurotoxicity, ā, ka taea te whakahaere i ēnei e rua mā te wawaotanga hauora e tika ana.
He aha i whiriwhiri ai koe i te rongoā CAR-T a BIOOCUS mō te NHL?
- Hangarau CAR-T Hou rawa atuKa whakamahia e BIOOCUS te hangarau CAR-T hou hei tuku i te maimoatanga tino matatau me te whai hua mō te NHL, mā te whakamahi i ngā rangahau hou hei whakarite i ngā putanga tino pai.
- Te Rōpū Tohunga HematologyKa mahi tahi tā mātou tīma maha-mātauranga o ngā tohunga toto, ngā tohunga pukupuku, me ngā tohunga ārai mate ki te whakarato i ngā mahere maimoatanga whaiaro mō ia tūroro.
- Te Angitu kua Whakamātauhia i roto i te Maimoatanga o te DLBCLKua rongoatia e BIOOCUS te tini o ngā tūroro NHL ki te rongoā CAR-T, ā, kua tutuki i a rātou ngā urupare whakamiharo, tae atu ki te murunga katoa me te oranga roa, inā koa mō ngā tūroro he DLBCL kua hoki anō ki te mate, he uaua rānei ki te rongoā.
- Tautoko Tūroro WhānuiMai i te kōrero tuatahi ki te tiaki i muri i te maimoatanga, ka tuku tautoko whānui a BIOOCUS ki ngā tūroro o te ao, kia maeneene ai, kia tautokohia hoki te haerenga puta noa i tā rātou tukanga maimoatanga.
Ngā Taunakitanga Hauora me ngā Reiti Angitu
-
Kua whakaatuhia e te rongoā CAR-T mō te NHL, inā koa mō te DLBCL, he hua tino pai i roto i ngā whakamātautau haumanu me ngā tono o te ao tūturu. Mō ngā tūroro kua maha ngā momo rongoā kua pāngia e te kore angitu, kua kitea he kōwhiringa whakaora ora te rongoā CAR-T.
- Kōrero mō te Tūroro: Te Lymphoma Pūtau-B Nui e horapa ana (DLBCL)—He Whakaora Whakamiharo i Muri i te Whakaora CAR-T
- Angitu Hauora: Te Whakaora CAR-T mō te DLBCL kua Hoki—He Ara ki te Whakamarietanga Katoa
- DLBCL Ātete-Maha-Raina: He Akoranga Take mō te Whai Huatanga o te Whakaora CAR-T i roto i te Lymphoma Matatau
E whakaatu ana ēnei rangahau take i te kaha whakarerekētanga o te rongoā CAR-T mō ngā tūroro e pāngia ana e te NHL, inā koa ko te hunga e pāngia ana e te DLBCL kaha me te ātete maha-raina. He maha ngā tūroro kua tutuki i te murunga roa, ā, kua hoki mai te kounga o te oranga i muri i te maimoatanga.
Raraunga Hauora
Ngā tohu mō te CD19+20CAR-T:Ngā tūroro e pāngia ana e te lymphoma kore-pūtau-B a Hodgkin
| Reiti CR kotahi marama | Te utu PR kotahi marama | Kotahi marama OR reiti | CRS≥3 | CRES≥3 |
| 71.95%(59/82) | 25.6(21/82) | 97.55(80/82) | 12.19%(10/82) | 0 |
Ngā tohu mō te CD19+22CAR-T:Te maimoatanga o ngā tūroro mate pukupuku toto B-lymphocytic whakapeka kua hoki mai te CD19 me te uaua ki te mahi
| Reiti CR kotahi marama | Te utu PR kotahi marama | Kotahi marama OR reiti | CRS≥3 | CRES≥3 |
| 92.1%(35/38) | 7.9%(3/38) | 100%(38/38) | 15.79%(6/38) | 0 |
Ngā tohu mō te BCMACAR-T:Te maimoatanga o te myeloma maha kua hoki mai me te uaua ki te whakatika
| Reiti CR kotahi marama | Te utu PR kotahi marama | Kotahi marama OR reiti | CRS≥3 | CRES≥3 |
| 72.41%(21/29) | 27.59%(8/29) | 100%(29/29) | 6.9%(2/29) | 0 |
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.



